PLYX

Polaryx Therapeutics, Inc. Common Stock

PLYX.US polaryx.com + Research + Basket
Employees 2
Phone 201 940 7236
Fiscal year end December
IPO Feb 02, 2026
Address South Tower, Paramus, NJ, United States, 07652
1.86
-0.03 (-1.59%)
USD · NASDAQ
52-week range
1.76
48.91
Trading at 0% of the 52-week range
Market Cap
89.01M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.22
Div. Yield
N/A
% Institutions
4.40%
% Insiders
69.92%

1 Year

-78.9%

3 Year

-78.9%

10 Year

-78.9%
Description

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

Actions

Add an action for PLYX.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Alex Yang J.D., L.L.M. CEO & Chair of Board 1970
Mr. G. Michael Landis CPA CFO & Director 1966
Mr. Andrew John O Chief Investment Officer 1973
Dr. Shrijay Vijayan M.B.A., Ph.D. Chief Scientific & Business Development Officer 1968
Mr. Wuxin Zhu P.M.P., Ph.D. Chief Chemistry, Manufacturing & Controls Officer 1980
Dr. Ralph William Charlton III, M.D. Chief Medical Officer 1970

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Feb 18, 2026 G. Michael Landis N/A Purchase 2.87K $2.79 $8.00K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Capital Management, LLC 1.66M Jun 30, 2026 3.33% $0.00 -0.03%
Geode Capital Management, LLC 171.00K Jun 30, 2026 0.34% $0.00 0.19%
Vanguard Fiduciary Trust Co 105.07K Jun 30, 2026 0.21% $0.00 0.49%
HRT FINANCIAL LLC 82.09K Jun 30, 2026 0.16% $0.00 0.00%
State Street Corp 58.10K Jun 30, 2026 0.12% $0.00 0.00%
BlackRock Inc 41.01K Jun 30, 2026 0.08% $0.00 0.00%
Jane Street Group LLC 31.44K Jun 30, 2026 0.06% $0.00 0.00%
Northern Trust Corp 27.99K Jun 30, 2026 0.06% $0.00 0.00%
Hanson Mcclain Inc 7.73K Jun 30, 2026 0.02% $0.00 0.00%
Vanguard Global Advisers, LLC 6.32K Jun 30, 2026 0.01% $0.00 0.00%
Tower Research Capital LLC 3.00K Jun 30, 2026 0.01% $0.00 68.56%
UBS Group AG 1.28K Jun 30, 2026 0.00% $0.00 -90.48%
Fortitude Family Office LLC 189.00 Jun 30, 2026 0.00% $0.00 0.00%
The Goldman Sachs Group Inc 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Millennium Management LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Morgan Stanley - Brokerage Accounts 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Squarepoint Ops LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Bank of America Corp 0.00 Jun 30, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.47M 2.95% ▲ 0.00% Sep 30, 2026
2 Fidelity Extended Market Index 65.12K 0.13% ▼ 0.53% Aug 31, 2026
3 Fidelity Total Market Index 26.45K 0.05% ▲ 0.00% Aug 31, 2026
4 Vanguard Balanced Index Inv 25.97K 0.05% ▲ 0.00% Sep 30, 2026
5 Vanguard MStar Inst Ttl StkMktIdxInstlPl 21.86K 0.04% ▲ 0.00% Sep 30, 2026
6 Fidelity Series Total Market Index 19.61K 0.04% ▲ 0.00% Aug 31, 2026
7 Fidelity Nasdaq Composite Index 19.04K 0.04% ▼ 33.53% Aug 31, 2026
8 Vanguard U.S. Eq Idx £ Acc 6.32K 0.01% ▲ 0.00% Sep 30, 2026

Financial Highlights

▼
Market Cap: $89.01M
Book Value: $0.22
Earnings/Share: $-0.14
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -42.52%
ROE (TTM): -96.56%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $90.85M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 47.34M
Shares Float: 7.17M
% Insiders: 69.92%
% Institutions: 4.40%
Short % Float: 0.55%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-1.56M
R&D
adjust
$-6.27M
Operating Income
subtotal
$-7.82M
Other / Non-Operating Items
adjust
$-1.16M
Net Income
subtotal
$-8.99M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PLYX.US!